by optimizenetz | Jan 4, 2023
The U.S. Food and Drug Administration (FDA) recently approved Saxenda, an injectable drug developed by Novo Nordisk. Although Saxenda is a formulation of the type 2 diabetes drug, liraglutide, also known as Victoza, Saxenda has been indicated for the treatment of...
by optimizenetz | Jan 4, 2023
Scientists from Cornell University saw promising results in an animal study that could one day lead to the creation of a probiotic pill that can help control blood glucose. Researchers treated rats with type 2 diabetes with an oral probiotic for 90 days. The animals...
by optimizenetz | Jan 4, 2023
Metformin, a drug used to treat type 2 diabetes, may be underused in the prevention of the chronic disease, according to a recent study conducted by researchers at UCLA. Their study showed that throughout a three year span, 2010-2012, only 3.7 percent of U.S. adults...
by optimizenetz | Jan 4, 2023
The U.S. Food and Drug Administration (FDA) recently announced that a certain class of drug can lead to increased levels of acid in the blood. Canaglifozin, dapaglifozin, and empagliflozin are considered a class of drug called sodium-glucose cotransporter-2 (SGLT2)...
by optimizenetz | Jan 4, 2023
An existing vaccination drug, Calmette-Guerin (BCG), has now been approved by the FDA for the start of phase II of a trial to determine the vaccine’s effectiveness in the treatment of type 1 diabetes. The announcement was made last week at the 75th Scientific Sessions...
